lorlatinib (lorbrena) Report issue

Small molecule Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem
Back

Drug Pricing Summary

AUS PBS

$61.8727 - $185.6182

VA Big4

$132.0310 - $395.8987

VA FSS

$177.2253 - $531.6753

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
lorlatinib 100 mg (TABLET) $185.6182 AUS PBS generic
  • Lorviqua (30)
    		•  Pfizer Australia Pty Ltd
    lorlatinib 100 mg (TABLET) $395.8987 VA Big4
  • Lorbrena (30)
    		•  Pfizer, Inc.
    lorlatinib 100 mg (TABLET) $531.6753 VA FSS
  • Lorbrena (30)
    		•  Pfizer, Inc.
    lorlatinib 25 mg (TABLET) $61.8727 AUS PBS generic
  • Lorviqua (90)
    		•  Pfizer Australia Pty Ltd
    lorlatinib 25 mg (TABLET) $132.0310 VA Big4
  • Lorbrena (30)
    		•  Pfizer, Inc.
    lorlatinib 25 mg (TABLET) $177.2253 VA FSS
  • Lorbrena (30)
    		•  Pfizer, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue